新型冠状病毒肺炎疫情下治疗药物监测实验室感染防控策略

Prevention and Control Strategy of Therapeutic Drug Monitoring Laboratory During the COVID-19 Epidemic

2019年12月以来,武汉暴发新型冠状病毒肺炎疫情。随着疫情蔓延,全国范围内确诊病例和疑似病例均呈上升趋势。华中科技大学同济医学院附属协和医院医、护、药、技人员奋战在抗击疫情的一线,治疗药物监测(TDM)药师每天处理大量血样标本,人员职业暴露保护及实验室生物安全管理显得非常重要。该文总结该院TDM药师在新型冠状病毒肺炎疫情下的感染防控策略和经验,以期为同行提供参考和帮助。

In December,2019,a series of pneumonia caused by the SARS-CoV-2 emerged in Wuhan.The confirmed and suspected cases are rising nationwide with the SARS-CoV-2 spread.Doctors,nurses,pharmacists and technicians from Union Hospital,Tongji Medical College,Huazhong University of Science and Technology are fighting on the front lines of the epidemic.Among them,therapeutic drug monitoring(TDM)pharmacists handle a large number of blood samples every day.It is very important to protect occupational exposure of personnel and manage the biosafety of laboratory.Therefore,the authors summarized the experience of infection prevention and control of TDM pharmacists under pneumonia outbreaks in their hospital,hoping to provide reference and help for the prevention and control of the infection for colleagues.